KEYNOTE-671: Randomized, double-blind, phase 3 study of pembrolizumab or placebo plus platinum-based chemotherapy followed by resection and pembrolizumab or placebo for early stage NSCLC.

被引：0

作者：

Wakelee, Heather A.

Liberman, Moishe

Kato, Terufumi

Tsuboi, Masahiro

Lee, Se-Hoon

He, Jie

Gao, Shugeng

Chen, Ke-Neng

Dooms, Christophe Alfons

Majem, Margarita

Eigendorff, Ekkehard

Martinengo, Gaston Lucas

Bylicki, Olivier

Rodriguez-Abreu, Delvys

Chaft, Jamie E.

Novello, Silvia

Yang, Jing

Keller, Steven M.

Samkari, Ayman

Spicer, Jonathan

机构：

[1] Stanford Univ, Stanford Canc Inst, Div Oncol, Dept Med, Stanford, CA USA

[2] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[3] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan

[4] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[5] Sungkyunkwan Univ, Div Hematol Oncol, Dept Internal Med, Samsung Med Ctr,Sch Med, Seoul, South Korea

[6] Chinese Acad Med Sci & Peking, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China

[7] Chinese Acad Med Sci & Pek, Dept Thorac Surg, Natl Clin Res Ctr Canc, Canc Hosp,Natl Canc Ctr, Beijing, Peoples R China

[8] Beijing Canc Hosp, Beijing, Peoples R China

[9] Univ Hosp Leuven, Leuven, Belgium

[10] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain

[11] Zentralklin Bad Berka GmbH, Bad Berka, Germany

[12] Sanatorio Parque, Santa Fe, Argentina

[13] HIA SAINTE ANNE, Toulon, France

[14] Complejo Hosp Univ Insular Materno Infantil, Las Palmas Gran Canaria, Spain

[15] Mem Sloan Kettering Canc Ctr, New York, NY USA

[16] Univ Turin, AOU San Luigi Orbassano, Turin, Italy

[17] Merck & Co Inc, Rahway, NJ USA

[18] Merck & Co Inc, Kenilworth, NJ USA

[19] McGill Univ, Ctr Hlth, Montreal, PQ, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 17期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA100

引用

页数：1